Invest now
Concord Biotech Balance Sheet Annual
BSE: 543960 | NSE: CONCORDBIO | ISIN: INE338H01029 | Sector: Biotechnology & Drugs1,446.65 +31.90 (2.25%)Updated : 07 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 2,234.73 | 2,034.25 | 1,700.71 | 1,513.98 |
| Accumulated Depreciation Total | -361.98 | -290.43 | -240.15 | -187.31 |
| Other Liabilities Total | 3.72 | 2.82 | 1.96 | 2.30 |
| Common Stock Total | 10.46 | 10.46 | 10.46 | 10.46 |
| Other Equity Total | 1.52 | - | - | - |
| Other Current Assets Total | 1.22 | 3.69 | 12.74 | 5.08 |
| Prepaid Expenses | 7.56 | 7.39 | 7.33 | 5.52 |
| Total Assets | 2,234.73 | 2,034.25 | 1,700.71 | 1,513.98 |
| Current Portof LT Debt/ Capital Leases | 0.88 | 2.34 | 7.85 | 25.15 |
| Additional Paid- In Capital | 81.97 | 81.97 | 81.97 | 81.97 |
| Cash | 12.19 | 0.90 | 15.14 | 3.50 |
| Total Equity | 2,018.98 | 1,812.72 | 1,526.65 | 1,290.00 |
| Long Term Investments | 95.05 | 34.76 | 3.05 | 10.32 |
| Retained Earnings( Accumulated Deficit) | 1,925.03 | 1,720.28 | 1,434.21 | 1,197.57 |
| Total Common Shares Outstanding | 10.46 | 10.46 | 10.46 | 10.46 |
| Property/ Plant/ Equipment Total- Gross | 1,228.04 | 1,134.65 | 1,026.63 | 952.79 |
| Tangible Book Valueper Share Common Eq | 192.82 | 173.17 | 145.90 | 123.29 |
| Goodwill Net | 0.40 | - | - | - |
| Total Liabilities | 215.74 | 221.53 | 174.06 | 223.98 |
| Total Debt | 2.32 | 2.97 | 9.74 | 31.55 |
| Short Term Investments | 418.66 | 334.53 | 266.52 | 136.93 |
| Cashand Short Term Investments | 430.85 | 335.44 | 281.67 | 180.38 |
| Total Receivables Net | 479.02 | 547.48 | 378.89 | 323.10 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Tax | 45.36 | 34.02 | 28.06 | 23.44 |
| Accounts Receivable- Trade Net | 460.20 | 521.65 | 350.84 | 274.55 |
| Property/ Plant/ Equipment Total- Net | 866.06 | 844.22 | 786.48 | 765.48 |
| Minority Interest | -3.85 | - | - | - |
| Total Current Liabilities | 169.08 | 184.06 | 142.16 | 191.84 |
| Total Inventory | 331.47 | 241.24 | 215.61 | 213.62 |
| Accounts Payable | 101.91 | 113.04 | 94.44 | 93.80 |
| Other Currentliabilities Total | 66.29 | 68.68 | 39.77 | 72.64 |
| Total Long Term Debt | 1.43 | 0.63 | 1.89 | 6.40 |
| Intangibles Net | 1.42 | 1.12 | 0.32 | 0.20 |
| Other Long Term Assets Total | 7.86 | 7.91 | 2.16 | 7.62 |
| Note Receivable- Long Term | 13.83 | 11.00 | 12.47 | 2.67 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,250.11 | 1,135.24 | 896.23 | 727.70 |
| Capital Lease Obligations | 1.43 | 0.63 | 1.89 | 0.16 |
| Accrued Expenses | - | 0.00 | 0.10 | 0.26 |
| Long Term Debt | - | 0.00 | 0.00 | 6.24 |
| Cash Equivalents | - | - | - | 39.95 |
*All figures in crores except per share values
Concord Biotech Quick Links
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,266.15+11.15(0.89%)
1,686.60+13.70(0.82%)
2,540.00+13.30(0.53%)
4,960.00-110.00 (-2.17%)
2,807.35-55.15 (-1.93%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.